The markets we decline can matter as much as the growth we approve

A board can approve a growth direction while the organisation's daily customer choices gradually produce a different one. Marketing sees part of that process because it helps decide which accounts receive attention and which propositions become public. I would bring that perspective into a boardroom carefully. It can help directors examine the relationship between stated strategy and the work management actually pursues. It does not give a marketing executive a complete account of the company's economics, risks or responsibilities, and I would not treat it as a substitute for learning those wider matters.

The eighty-four-invitation review illustrates the distinction. As an executive, I supported thirty-two refusals and committed proposal effort to the remaining fifty-two submissions. A board should not need to approve each of those choices. It could reasonably ask whether the accumulated refusals indicate a durable decision about markets or capabilities. If the company continues to describe a segment as important while repeatedly declining the work it offers, the gap deserves explanation. Directors can test that pattern without becoming a second bid committee. The appropriate management account would connect the repeated choices to the strategic intention and identify what might cause the direction to change.

I would also ask how the company learns from opportunities it has declined. Missing outcomes can make a policy look more certain than it is. The fact that an unsubmitted bid did not create a difficult contract says little about whether the refusal was wise. A proportionate review of selected cases may reveal changing requirements, misunderstandings or capabilities worth developing. The board's concern is whether management has a credible learning process, not whether every hypothetical contract has been valued. Inventing revenue or profit for an alternative that never occurred would give the discussion an appearance of precision without the corresponding evidence.

Commercial claims present a related oversight question. The selected shipment account contained 608 deliveries inside the original window out of 640, with later amendments described separately. My executive responsibility concerned how that evidence entered proposal material. A director's responsibility would be different: understand how significant claims are supported, who owns the definitions and what happens when the proposition or evidence changes. Asking those questions is more useful than rewriting the headline during a board meeting. It keeps attention on the process and consequence while preserving management's responsibility for communication and operations.

The current industrial-parts investigation raises the issue of staged commitment. US$360,000 was authorised for research, not for launching a new service proposition. Fifteen interviews out of twenty-four are complete. The board should be able to see which later decision the research is intended to inform and whether the programme remains capable of recommending that the company should not proceed. If public language or preparatory expenditure makes entry appear settled before that point, the staged process may no longer be a real choice. I would ask management to explain the remaining alternatives and the authority needed for each, rather than infer launch approval from the existence of a research budget.

My own position is that of an executive who has presented to a board since January 2020, not a serving director. A first non-executive appointment would require deliberate preparation and an understanding of collective responsibility. I would want the chair to explain how my commercial experience complements the board and where other members' expertise should lead. Financial reporting, risk and governance matters cannot be reduced to the marketing perspective simply because that is the perspective I know best. Effective contribution includes recognising when to ask a question, when to listen and when an operating detail belongs outside the board's discussion.

Relationships and capacity would be examined before accepting any role. My employer's shipper and carrier connections could matter even where a prospective company appears to operate in a different sector. Disclosure should be factual and current, with qualified advice where needed. Twenty-two annual days is a planning allowance subject to the actual calendar, preparation and exceptional demands, not a universal capacity claim. I would not accept restrictions so extensive that the contribution sought could not be made. The purpose of a board role should be useful participation in the company's oversight, not the addition of a title to this public record.